申请人:Ciba-Geigy Corporation
公开号:US04595677A1
公开(公告)日:1986-06-17
Tetrapeptides of the formula I, ##STR1## in which R.sup.1 represents hydrogen or acyl, R.sup.2 represents alkyl or aralkyl, R.sup.3 represents free or functionally modified hydroxy, R.sup.4 represents free or substituted amino or free or etherified hydroxy, and -Pro-, -Phe- and -His- respectively represent the bivalent radicals of the amino acids proline, phenylalanine and histidine or the (D)-isomers thereof, salts of such compounds having salt-forming groups, and processes for their manufacture. The compounds inhibit the action of the enzyme renin and can be used as antihypertensives and for the treatment of cardiac insufficiency.
公式I的四肽,其中R.sup.1代表氢或酰基,R.sup.2代表烷基或芳基烷基,R.sup.3代表自由或功能性修饰的羟基,R.sup.4代表自由或取代氨基或自由或醚化羟基,-Pro-,-Phe-和-His-分别代表脯氨酸,苯丙氨酸和组氨酸的二价基团或其(D)异构体,具有形成盐的基团的这些化合物的盐以及它们的制造过程。这些化合物抑制酶肾素的作用,可用作降压剂和治疗心力衰竭。